Nanosphere's Bloodstream Infection Test Designated Moderate Complexity by FDA
01 nov. 2012 18h20 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today that it...
Nanosphere to Release Q3 2012 Results and Hold Investor Call on Wednesday, November 7
26 oct. 2012 10h43 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 26, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its...
Nanosphere Test Accurately Detects a Broad Panel of Bacterial Targets and Resistance Determinants Directly From Blood Culture
22 oct. 2012 10h29 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 22, 2012 (GLOBE NEWSWIRE) -- Nanosphere's (Nasdaq:NSPH) Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) (IUO), based on the company's proprietary array-based...
Nanosphere, Inc. Appoints Roy N. Davis to Board of Directors
10 oct. 2012 17h15 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 10, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced the...
Nanosphere to Present at Craig-Hallum Alpha Select Conference
21 sept. 2012 09h24 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that Roger...
Nanosphere to Present at UBS Global Life Sciences Conference
10 sept. 2012 11h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that...
Nanosphere to Present at Rodman & Renshaw Annual Global Investment Conference
29 août 2012 12h04 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Aug. 29, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
Nanosphere Announces Second Quarter 2012 Results
07 août 2012 08h00 HE
|
Nanosphere, Inc.
Gram-positive blood culture test cleared by the FDA on June 27th
Entered into marketing and distribution agreement in Europe with Thermo Fisher Scientific (refer to Nanosphere's April 30th...
Nanosphere to Release Q2 2012 Results and Hold Investor Call on Tuesday, August 7
25 juil. 2012 13h10 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., July 25, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its...
Nanosphere, Inc. Announces Exercise of Over-Allotment and Closing of Common Stock Offering
24 juil. 2012 15h10 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., July 24, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...